Surface Oncology - Stock Price History | SURF

Historical daily share price chart and data for Surface Oncology since 2018 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Surface Oncology as of October 23, 2018 is 7.96.
Surface Oncology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.230B $0.045B
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.435B 19.38
Abbott Laboratories (ABT) United States $120.206B 24.38
Stryker (SYK) United States $62.741B 24.24
Boston Scientific (BSX) United States $50.643B 26.34
Baxter (BAX) United States $36.875B 25.10
Zimmer Biomet Holdings (ZBH) United States $25.257B 16.23
ResMed (RMD) United States $14.644B 29.07
Smith & Nephew SNATS (SNN) United Kingdom $14.612B 0.00
Perrigo (PRGO) Ireland $9.748B 13.83
Canopy Growth (CGC) Canada $9.572B 0.00
Bio-Rad Laboratories (BIO) United States $8.308B 53.35
Hill-Rom Holdings (HRC) United States $5.726B 19.42
Haemonetics (HAE) United States $5.555B 50.69
ICU Medical (ICUI) United States $5.444B 36.89
Insulet (PODD) United States $5.198B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.212B 0.00
Hutchison China MediTech (HCM) China $3.983B 0.00
Agios Pharmaceuticals (AGIO) United States $3.643B 0.00
Neogen (NEOG) United States $3.276B 49.61
NuVasive (NUVA) United States $3.270B 31.02
National Vision Holdings (EYE) United States $3.195B 70.55
Quidel (QDEL) United States $2.516B 51.55
NxStage Medical (NXTM) United States $1.836B 0.00
Phibro Animal Health (PAHC) United States $1.796B 25.58
Cardiovascular Systems (CSII) United States $1.258B 724.80
AtriCure (ATRC) United States $1.059B 0.00
VAREX IMAGING (VREX) United States $0.987B 16.12
Owens & Minor (OMI) United States $0.914B 9.77
OraSure Technologies (OSUR) United States $0.909B 59.44
Cerus (CERS) United States $0.879B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.875B 25.83
PetIQ (PETQ) United States $0.860B 28.12
Surmodics (SRDX) United States $0.853B 103.08
MacroGenics (MGNX) United States $0.766B 0.00
Omeros (OMER) United States $0.749B 0.00
Meridian Bioscience (VIVO) United States $0.661B 22.59
Insys Therapeutics (INSY) United States $0.607B 0.00
LeMaitre Vascular (LMAT) United States $0.542B 26.98
Lantheus Holdings (LNTH) United States $0.510B 15.85
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.423B 0.00
Quanterix (QTRX) United States $0.405B 0.00
Evolus (EOLS) United States $0.359B 0.00
Cytosorbents (CTSO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.76
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.295B 0.00
Rockwell Medical (RMTI) United States $0.221B 0.00
BioLife Solutions (BLFS) United States $0.209B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Bovie Medical (BVX) United States $0.168B 0.00
Fonar (FONR) United States $0.146B 7.21
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
United-Guardian (UG) United States $0.079B 17.33
Imprimis Pharmaceuticals (IMMY) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.073B 0.00
Female Health (VERU) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.062B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 18.19
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Senestech (SNES) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00